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Pregnancy-associated malaria is a major global health concern. To assess the Plasmodium falciparum burden in pregnancy we con-
ducted a cross-sectional study at Mulago Hospital in Kampala, Uganda. Malaria prevalence by each of three measures—peripheral
smear,placentalsmear,andplacentalhistologywas9%(35/391),11.3%(44/389),and13.9%(53/382)respectively.Together,smear
and histology data yielded an infection rate of 15.5% (59/380) of active infections and 4.5% (17/380) of past infections; hence 20%
had been or were infected when giving birth. A crude parity dependency was observed with main burden being concentrated in
gravidae 1 through gravidae 3. Twenty-two percent were aﬄicted by anaemia and 12.2% delivered low birthweight babies. Active
placental infection and anaemia showed strong association (OR = 2.8) whereas parity and placental infection had an interactive
eﬀe c to nm e a nb i r t h w e i g h t( P = .036). Primigravidae with active infection and multigravidae with past infection delivered on
average lighter babies. Use of bednet protected signiﬁcantly against infection (OR = 0.56) whilst increased haemoglobin level
pr otectedagainstlo wbirth weight(OR= 0.83)irrespectiveofinfectionstatus.Albeitahighattendanceatantenatalclinics(96.8%),
there was a poor coverage of insecticide-treated nets (32%) and intermittent preventive antimalarial treatment (41.5%).
1.Introduction
Malaria is a major public health problem aﬀecting between
300–500 million people annually. Plasmodium falciparum is
responsible for the main disease burden aﬄicting primarily
sub-Saharan Africa. In areas with stable malaria transmis-
sion, due to protracted exposure to infectious bites, partial
protective immunity to clinical malaria is gradually acquired
with increasing age. Severe P. falciparum malaria is thus
predominantly a childhood disease. There is however one
exception to this general rule: pregnancy-associated malaria
(PAM). Despite their semi-immune status, women become
more susceptible to malaria upon pregnancy. In endemic
areas, approximately 25 million pregnancies are at risk of
P. falciparum infection every year, and 25% of these women
have evidence of placental infection at the time of delivery
[1–3].
Clinical features of infection during pregnancy vary with
the degree of preexistingimmunity and thus the epidemio-
logical setting. In high-transmission areas,maternalanaemia
andlowbirthweight(LBW),asaresultofprematurityand/or
intrauterine growth restriction (IUGR), are the main adverse
outcomes of placental infection and tend to be more severe
in ﬁrst pregnancies and in younger mothers [2, 4–8]. These
eﬀects are less marked by gravidity in low-transmission areas
[9]. Moreover, LBW babies are in general at increased risk of
death during infancy. Each year between 100000 to 300000
infant deaths may be attributable to maternal malaria in
Africa [10, 11].
The pathophysiological processes preceding adverse out-
comes in PAM are initiated by the accumulation of P. falci-
parum-infected red blood cells (pRBCs) in placental intervil-
lous spaces, causing inﬂammatory responses and deposition
ofﬁbrinoidmaterial.Adhesiveinteractionsbetweenparasite-
encoded erythrocyte surface antigens and intervillous host
receptors such as chondroitin sulphate A (CSA), hyaluronic
acid (HA), and nonimmune immunoglobulins (Igs) are
believed to be involved in the sequestration process [12].2 Malaria Research and Treatment
The exact details of how sequestration causes LBW are
unknown. Local inﬂammatory immune responses in the
infected placenta may induce early labour [13]. IUGR
appears to be related to reduced nutrient transport to the
foetusduetohighparasiteandinﬂammatorycelldensity[13,
14]. Maternal anaemia may also independently contribute to
IUGR, most likely via a reduction in oxygen transport to the
foetus [13].
In Uganda, the overall burden of malaria is high and its
adverse outcomes to the infected mother and the unborn
child are widespread. There is growing awareness that
pregnancy-associated malaria is also of importance in areas
of low and seasonal transmission worldwide. Although
Uganda is regarded as being a malaria-endemic region, the
transmission level varies considerably across the country
[15].Similar tostudiesfromothercountries,data onmalaria
burden are mainly available from areas of high transmission.
In light of this, we conducted a cross-sectional study to
assess the PAM burden in a periurban/urban setting with
low, seasonal malaria transmission. Moreover, this is the ﬁrst
study providing baseline data on the burden of PAM and
its possible adverse outcomes (anaemia, LBW) at Uganda’s
National Referral Hospital at Mulago.
2. Patientsand Methods
2.1. Study Site. Mulago Hospital serves as Uganda’s National
Referral Hospital and is situated in the capital city of Kam-
pala. In Uganda, there is stable P. falciparum transmission
in 95% of the country. The remaining 5% of the country,
mainly the highland areas with altitudes >1,600m, are
subjecttolowandunstablemalariatransmission.Kampalais
located1,300–1,500mabovethesealevelclosetotheequator
and experiences a tropical climate with rainfalls throughout
the year. The population in the area experiences low-
intermediate malaria transmission with the highest peaks
toward the end of the two major rainy seasons (March to
May and October to December). This study was conducted
from October 2004 to January 2005. The rainfall patterns in
Kampala were typical, with two peaks, during 2004. There
was an average of 146.7mm of rainfall between October
and December 2004 and 40mm in January 2005, a level
comparable to the corresponding seasons in previous years.
Since the city is built on hills and valleys, the entomological
infection rates (EIR) vary considerably depending on the
residential/occupational area. Water usually collects in the
valley ﬂoors resulting in breeding sites for the anopheline
mosquitoes. But generally speaking the EIR is low (<10 bites
per person per year). Except for the main commercial centre,
the city and the surrounding areas are essentially rural.
Mulago Hospital has 33,000 antenatal attendances and
23,000 deliveries per year, a maternal mortality ratio of 505
deaths per 100,000 live births, a stillbirth rate of 5%, and
an HIV prevalence of about 11% among pregnant women.
The current national policy for prevention of malaria in
pregnancy in Uganda is the use of insecticide-treated bednet
and intermittent preventive treatment with two doses of
sulfadoxine-pyrimethamine. In Uganda, pregnant women
are also given iron and folic acid supplementation and
antihelminth drugs to prevent anaemia and hookworm
infestation, respectively.
2.2. Study Population and Data Collection. From October
2004 to January 2005, women delivering at the Mulago
Hospital labour suite, aging ≥15 years and ≥28 weeks
of gestation, were recruited to the study. Patients with
cardiac disease, chronic hypertension, renal disease, clinical
AIDS, or diabetes and those with obstetric complications
during the present pregnancy, such as preeclampsia, eclamp-
sia, antepartum haemorrhage, and chorioamnionititis were
excluded from the study. Full informed consent (or assent
for those <18 years of age) was obtained from all the
participants. On average, ﬁve to seven participants were
recruited consecutively per day, from 8.00 am to 5.00 pm
excluding weekends and public holidays. All ethical aspects
of the study were granted by the Makerere University
Medical School Research and Ethics Committee and Uganda
National Council for Science and Technology (permit No.
MV922), and the ethical committee at Karolinska Institutet,
Sweden (permit No. 04-533/2). A precoded, standardized
questionnaire was used to record pregnancy history, clinical
examination outcome, and pregnancy outcome for each
study subject. Some key aspects covered included area
of residence, age, marital status, occupation, education,
parity, visits to antenatal clinic (ANC), bednet use, use of
intermittent preventive antimalarial treatment (IPT), iron
and folic acid supplementation, gestational age, birth status
(live or stillbirth), and birthweight. The information on use
of IPT, iron and folic acid supplementation was obtained
from interview and/or antenatal card.
2.3. Sample Collection and Laboratory Studies. Venous blood
was collected within a few hours (2–4 hours) prior to
delivery for peripheral blood diagnosis of malaria and
for haemoglobin testing. After delivery, the placentas were
collected in 0.9% NaCl for smear and histological assessment
of malaria. A small incision was made paracentric on the
maternal-facing side of the placentas to prepare blood ﬁlms.
Thick and thin blood ﬁlms of peripheral and placental
blood were stained by Giemsa, and malaria diagnosis was
assessed by microscopy following standard procedures. A
small biopsy of the maternal-facing surface of each collected
placenta was also removed and preserved in 10% neutral
buﬀered formalin. The biopsies were paraﬃne m b e d d e d
and stained with haematoxylin and eosin for histological
evaluation of placental malaria infection. The slides were
examined by a pathologist blinded to other patient data.
Reexamination was performed by two diﬀerent pathologists
in all cases where histology and blood ﬁlms were in
disagreement.
2.4. Deﬁnitions. Upon histological assessment, placental
biopsies were classiﬁed according to the following criteria
[16, 17]: (a) active acute infection: parasites present in
maternal erythrocytes, (b) active chronic infection: presence
of parasites and a signiﬁcant amount of pigment deposition
in ﬁbrin or monocytes within ﬁbrin, (c) past infection:Malaria Research and Treatment 3
presence of pigment within ﬁbrin only, no parasites, and
(d) not infected: no evidence of parasites or pigment. Low
birthweight is deﬁned as weight <2500g. Anaemia is deﬁned
as haemoglobin (Hb) level <11g/dl and severe anaemia
as Hb <7g/dl. Preterm delivery is regarded as deliveries
occurring prior to 37 weeks of gestation. Bednet users refer
to individuals using net of any category (untreated as well
as insecticide-treated nets). ITN users refer to those using
insecticide-treated nets only.
2.5. Statistical Analysis. Data were entered and veriﬁed by
two independent individuals using Epi Info version 6.1
and exported to SPSS version 12.0 for further analysis.
Placental P. falciparum infection, anaemia, and birthweight
were regarded as principal outcomes. Potential risk factorsor
confounders considered were area of residence, literacy, age,
use of bednet, IPT, and iron and folic acid supplementation.
Following the assessments of the crude eﬀect of each risk
factor, the list of interesting risk factors was organised into
three blocks: background, intermediate and proximate risk
factors. Background risk factors were adjusted for each
other: intermediate for background and intermediate, and
proximate for all other risk factors. Adjusted odds ratios
were obtained using logistic regression. The signiﬁcance
of each variable was reconsidered by backward stepwise
elimination. Variables with a P-value of <.1 were included
in the ﬁnal model. Due to the presence of missing values
in the dataset, missing value analysis was performed prior
to logistic regression modelling in order to assess the total
number and randomness of missing values.
Proportions were compared using χ2 tests and validated
at a 5% signiﬁcance level. Multiway univariate analysis of
variance (ANOVA) was used to study the eﬀects of placental
infection, gravidity and age, and combinations thereof, on
haemoglobin level and birthweight.
3. Results
3.1. General Description. A total of 399 women who con-
sented to take part in the study were recruited between
October 2004 and January 2005. The age of the partici-
pants ranged from 15 to 44 years, median 20 (IQR: 18–
25). Most participants were residents of Kampala (68.6%)
and Wakiso (22.9%) districts. The majority had primary
(46.4%) or secondary (42.3%) level of education; 66.3%
were housewives or unemployed; 74% were married. Most
women(96.8%)hadattendedanantenatalclinicatleastonce
during the present pregnancy. One hundred and sixty ﬁve
(41.5%) had received intermittent preventive antimalarial
treatment (IPT); of these, the majority had received one dose
(74.5%), whereas 20.5% had received the two recommended
doses. Sulfadoxine-pyrimethamine (SP) was the drug of
choice (89.3%). Other preventive measures taken during
pregnancy consisted of the use of mosquito bednets: two
thirds (267/397; 67.3%) utilized nets of any sort: 32%
(127/397) were strict insecticide-treated net (ITN) users.
Most women had also received iron (79.3%) and folic acid
(70.4%) supplementation during the present pregnancy (see
Table 1 for general characteristics). The study population
consisted of 196 (49.4%) gravidae 1 (G1) or primigravidae,
142 (35.8%) gravidae 2-3 (G2-3), and 59 (14.9%) gravidae
4o ra b o v e( ≥G4). A number of factors showed crude asso-
ciations with gravidity. Primigravidae tended to be younger
(P<. 0001) and more literate (P = .001), delivered more
low-birthweight babies (P = .06), used less IPT (P<. 0001),
and were more aﬄicted by placental malaria infection (P =
.035) as compared to multigravidae (G2 and above; Table 2).
3.2. Prevalence of Malaria. The prevalence of malaria by
each of the three measures peripheral smear, placental smear
and placental histology, was 9% (35/391), 11.3% (44/389)
and 13.9% (53/382), respectively. Out of 53 women with
histological evidence of infection, 34 (64.1%) were classiﬁed
as acute, 2 (3.8%) as chronic, and 17 (32.1%) as past
infection. P. falciparum was the sole species found in all
cases. A total of 380 cases, where placental histology and the
corresponding blood ﬁlm data were available, were used for
further associative analysis. In order to avoid loss of data,
all cases diagnosed as being acute or chronic infection by
histology or as P. falciparum positive by placental blood ﬁlm
examination were regarded as active infection. Based on the
new case deﬁnition criteria, a total of 15.5% (59/380) and
4.5% (17/380) had active versus past placental infection,
respectively. Peripheral parasites were present in 50.9%
(28/55)and5.9%(1/17)ofcaseswithactiveversuspastinfec-
tion. In patients with no evidence of active or past placental
infection, only 1.3% (4/304) had peripheral parasitaemia.
Placental infection could thus be used as a reliable measure
of malaria burden in the remainder of the analysis.
3.3.PrevalenceofAnaemiaandLowBirthweight. Twenty-two
percent of the women were anaemic (Hb <11g/dl) prior
to delivery. Severe anaemia (Hb <7g/dl) was however
uncommon (3/389; 0.8%). The mean haemoglobin level was
12.3g/dl (IQR = 10.9–13.4) (Table 1). The overall prevalence
of stillbirths was 2.8% (11/389) and preterm deliveries 3.1%
(12/389). Among live-born babies, 12.2% (46/378) were of
low birthweight and the mean birthweight was 3100g (IQR
= 2800–3500) (Table 1).
3.4. Risk Factors Associated with Placental Malaria. Table 3
illustrates crude and adjusted odds ratios for factors associ-
ated with placental P. falciparum infection. Whilst higher age
anduseofbednetwerefoundprotective,districtofresidence,
educational level, and use of IPT showed no association.
Being multigravid (≥G4) was protective in the crude analysis
(OR = 0.38; CI =0.14–0.88; P<. 05) (Figure 1(a)); the
eﬀect was, however, lost in the adjusted model (Table 3).
As gravidity and age are highly correlated variables, an age-
stratiﬁed analysis was performed to separate out the eﬀect
of the two. Gravidity groups were stratiﬁed by two age
groups (15–19 years versus ≥20 years). A trend of higher
infection rate, although not signiﬁcant, was observed in
young primigravidae (G1: 33/126 = 23.1% versus ≥G2: 4/28
= 14.3%; OR = 2.1; CI = 0.69–6.6; P = .18). The analysis was,4 Malaria Research and Treatment




























Visit to ANC (%) 96.8
Received IPT (%) 41.5
Use of bednet (%) 67.3
Use of ITN (%) 32.0
Median Hb level (g/dl) 12.3 (IQR: 10.9–13.4)
Hb <11g/dl (%) 22.0
Folic acid supplementation (%) 70.4
Iron supplementation (%) 79.3
Median birthweight (g) 3100 (IQR: 2800–3500)
LBW (%) 12.2
Preterm delivery (%) 3.1
Stillbirth (%) 2.8
Caesarean (%) 17.6




ANC: antenatal clinic, at least one visit during the present pregnancy.
IPT: intermittent preventive antimalarial treatment, at least one dose.
ITN: insecticide-treated net. LBW: low birthweight.
however, limited by the absence of higher parities (≥G4) in
the younger age group.
3.5.RiskFactorsAssociatedwithAnaemia. Thecrudeanalysis
and the adjusted ﬁnal model, both, identiﬁed a strong
association between active placental malaria infection and
anaemia (OR = 2.76; CI = 1.4–5.5; P = .003) (Table 4,
Figure 1(b)) .T h em e a nh a e m o g l o b i nl e v e lw a s1 1 . 6g / d l( C I :
11.1–12.3) versus 12.6g/dl (CI: 12.3–12.9) in patients with
active infection or no infection, respectively, (P = .02). No
associations were observed with any of the other considered
risk factors. Of note, use of bednet showed a trend towards a
protective eﬀect (Table 4).
3.6. RiskFactors Associated with Low Birthweight. Factors
associated with low birthweight are outlined in Table 5.
Increased haemoglobin level and to some extent age showed
protective association with low birthweight. Increased gra-
vidity (≥G4) showed a crude but not adjusted protective
association. No overall associations were found with district
of residence, education, placental malaria infection, use of
bednet, IPT, and iron and folic acid supplementation. A
signiﬁcant association was, however, found when interac-
tions between gravidity and placenta infection groups and
their eﬀect on mean birthweight were analyzed (Table 6;
P = .036). However, interpretation of the eﬀect size
of gravidity and placental infection on mean birthweight
becomes complicated in light of the signiﬁcant covariation
of gravidity by age (P = .034; see Table 6 and Supplementary
table in supplementary material available online at doi:
10.406/2010/913857). To analyze the pattern of the identiﬁed
interaction, the age parameter was thus ﬁxed at a mean
value in all subgroups (Tables 7 and 8). The birthweight was
on average lower in primigravidae irrespective of infection
status. The smallest mean birthweight in primigravidae
were found in mothers with active infection, whereas in
multigravidae it was observed in mothers with past infection
(Tables 7 and 8).
4. Discussion
Data on the burden of malaria in pregnancy, in particular
from areas of low transmission, are scarce in Uganda as
well as in other countries. A cross-sectional study was
thus conducted from October 2004 to January 2005 in the
periurban/urban setting of Kampala where the population
experiences relatively low and seasonal malaria transmission.
Exploiting placenta histology and blood ﬁlm examination,
a high proportion of the study population was found
burdened with active placental infection (15.5% in total).
In addition, histological examination identiﬁed a number of
women with past placental infection (4.5%). Adverse clinical
outcomes associated with malaria in pregnancy are linked
to pathological changes in the parasite-burdened placentas
[18], and histology is the only method that provides insight
on pathological changes as well as timing of infection
(acute, chronic, and past). Past infections would have been
missed had we relied solely on blood ﬁlm examination.Malaria Research and Treatment 5
Table 2: General characteristics by gravidity.
Characteristics Primigravidae (%) Multigravidae (%) P-value for gravidity change
a
G1 (n 196) G2-3 (n 142) ≥G4 (n 59)
District of residence
Kampala 70.2 67.4 66.7 .97
Wakiso 22.0 23.2 25.0
Other 7.9 9.4 8.3
Age (years)
<.0001 15–19 68.9 14.9
≥20 31.1 85.1
Education
Illiterate 4.4 7.1 12.5 .001
Primary 38.3 52.0 60.7
Higher education 57.2 40.9 26.8
Visit to ANC 97.2 95.6 98.2 .61
Recieved IPT 31.6 49.3 55.7 <.0001
Bednet (of any kind) 65.8 65.9 75.0 .38
Stillbirth 3.7 2.0 .31
LBW (<2500g) 15.2 9.0 .06
Anaemia (<11g/dL) 23.2 22.6 18.3 .73
Placental malaria
.035 Active infection 19.6 12.5 10.3
Past infection 3.8 7.4 0
ANC: antenatal clinic, at least one visit during the present pregnancy.
IPT: intermittent preventive antimalarial treatment, at least one dose.
aChi-square test used. Age, stillbirth, and LBW were analysed using multigravidae as a pooled group (≥G2).
Table 3: Risk factors associated with placental malaria.
Factor level Risk factor Crude OR Adjusted OR (95% CI) P-value
Background Age (continuous per year) 0.95∗ 0.95 (0.89–1.00) .066
District of residence
Kampala 1.0 1.0
Wakiso 1.18 1.4 (0.74–2.60) .31
Other 1.80 1.9 (0.79–4.74) .15
Education (continuous per level) 0.79 0.75 (0.48–1.17) .21
Intermediate Gravidity
G1 1.0 1.0
G2-3 0.81 1.0 (0.54–2.07) .88
≥G4 0.38∗ 0.72 (0.21–2.50) .61
Proximate Received IPT
None 1.0 1.0
1d o s eo fS P 0.93 1.11 (0.60–2.07) .73
2d o s e so fS P 0.55 0.49 (0.16–1.49) .21
Used bednet 0.56∗ 0.56 (0.31–0.99) .046
∗Signiﬁcant associations (P<. 05).
Of note, a minor proportion of women with no evidence
of placental infection (1.3%) were aﬄicted by peripheral
parasites. Individuals in endemic areas can, however, harbor
circulating parasites asymptomatically. Hence, the mere
presence of peripheral parasites coinciding with pregnancy
is not a proof of their involvement in placental sequestration
and adverse clinical outcomes. Placental infection was thus
used as a reliable measure of PAM burden in this study.
The majority of the placental malaria cases was concen-
trated among gravidae 1 through 3. Observed pattern may
be explained by the development of protective antibodies
by successive pregnancies. Acquired antibodies recognize6 Malaria Research and Treatment
Table 4: Risk factors associated with anaemia (<11g/dl).
Factor level Risk factor Crude OR Adjusted OR (95% CI) P-value
Background Age (continuous per year) 1.0 0.98 (0.93–1.04) .51
District of residence
Kampala 1.0 1.0
Wakiso 1.15 1.11 (0.60–2.07) .74
Other 0.40 0.44 (0.13–1.52) .20
Education (continuous per level) 1.14 1.14 (0.73–1.77) .57
Intermediate Gravidity
G1 1.0 1.0
G2-3 1.04 1.0 (0.56–1.80) .98
≥G4 0.86 0.70 (0.30–1.63) .51
Placental malaria (active + past) 2.31∗ 2.35 (1.27–4.35) .006
Active infection 2.66∗ 2.76 (1.40–5.45) .003
Past infection 1.37 1.53 (0.44–4.66) .48
Proximate Used bednet 0.73 0.67 (0.37–1.20) .18
Received IPT
None 1.0 1.0
1d o s eo fS P 1.05 1.17 (0.64-2.13) .62
2d o s e so fS P 1.46 1.17 (0.47-2.86) .74
Iron supplementation 1.51 1.96 (0.67-5.71) .22
Folic acid supplementation 1.26 0.70 (0.29-1.71) .43
∗Signiﬁcant associations (P<. 05).
Table 5: Risk factors associated with low birthweight (<2500 g).
Factor level Risk factor Crude OR Adjusted OR (95% CI) P-value
Background Age (continuous per year) 0.91∗ 0.93 (0.86–1.0) .068
District of residence
Kampala 1.0 1.0
Wakiso 0.86 0.98 (0.45–2.13) .97
Other 0.21 0.21 (0.01–1.06) .14
Education (continuous per level) 1.1 1.05 (0.61–1.81) .87
Intermediate Gravidity
G1 1.0 1.0
G2-3 0.69 1.22 (0.54–2.77) .63
≥G4 0.30
∗ 0.70 (0.14–3.51) .67
Placental malaria (active + past) 1.48 0.72 (0.29–1.80) .48
Active infection 1.61 0.69 (0.24–1.96) .49
Past infection 1.05 0.77 (0.16–3.77) .75
Haemoglobin level 0.83
∗ 0.83 (0.70–0.99) .033
Proximate Use of bednet 1.33 1.65 (0.72–3.79) .24
Received IPT
None 1.0 1.0
1d o s eo fS P 1.20 1.21 (0.56–2.63) .63
2d o s e so fS P 0.84 0.96 (0.30–3.09) .94
Iron supplementation 0.74 0.19 (0.02–1.58) .12
Folic acid supplementation 1.0 4.48 (0.57–34.9) .15
∗Signiﬁcant associations (P<. 05).Malaria Research and Treatment 7
Table 6: Multiway ANOVA—birthweight as dependent variable.
Type III sum of squares Df Mean square F P-value Partial Eta Squared
Corrected model 9.063 E6 7 1294773.8 4.45 .000 0.078
Intercept 6.878 E7 1 6.878E7 236.21 .000 0.39
Gravidity 1832523.0 1 1832523.0 6.29 .013 0.017
Placental malaria 420890.8 2 210445.4 0.72 .49 0.004
Age 1055645.5 1 1055645.5 3.63 .058 0.010
Gravidity∗ age 1314216.3 1 1314216.3 4.51 .034 0.012
Gravidity∗ placental malaria 1957844.9 2 978922.4 3.36 .036 0.018
Error 1.074 E8 369 291178.3
Total 3.858 E9 377
Corrected total 1.165 E8 376
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Figure 1: (a) Prevalence of placental malaria by gravidity. ∗P<. 05 for crude comparison between primigravidae and multigravidae. (b)
Prevalence of anaemia by placental malaria infection status: active, past, or no infection. ∗P<. 005 for comparison between active versus no
infection groups.
an antigenically and functionally distinct subpopulation of
pRBCs, which is clonally expanded owing to the new niche
of growth provided by the placenta [19, 20]. The func-
tional distinction between pregnancy-associated parasites
and parasites of nonpregnant individuals has partly been
explained by the CSA-adhesion ability of the former [21, 22].
Accordingly, in a related study [23], we found CSA-adhesion
to constitute a prominent functional feature of Ugandan
placental pRBCs. The parity dependency, found herein, was
however not as marked as previously reported from high-
transmission areas [24]. This shift may be a reﬂection of
the lower transmission level in the area but may also reﬂect8 Malaria Research and Treatment
Table 7: Eﬀect of gravidity and placental malaria infection on mean birthweight.
Placental malaria Mean birthweight Std. error (95% CI)
Primigravidae
Active infection 3015 105.8 (2810–3220)
Past infection 3180 207.5 (2775–3590)
No infection 3180 65.7 (3050–3310)
Multigravidae
Active infection 3440 114.0 (3220–3665)
Past infection 2930 168.9 (2600–3265)
No infection 3260 48.0 (3170–3355)
The table depicts the marginal mean birthweights estimated from the following model: (Intercept) gravidity, placental malaria, age, gravidity
∗age,
gravidity
∗placental malaria. Covariates appearing in the model are ﬁxed at the following values: age = 21.91.
Table 8: Pairwise comparisons of birthweight means across gravidity versus placental malaria subgroups.
95% CI
Pair 1 versus Pair 2 Diﬀerence in mean birthweight Std. error df P-value Lower Upper
G1∗ active
≥G2∗ active −427.6 155.5 1 .006 −732.5 −122.8
≥G2∗ no infection −247.6 116.2 1 .033 −475.3 −19.9
G1∗ no infection ≥G2∗ active −265.3 131.5 1 .044 −523.1 −7.5
≥G2∗ active ≥G2∗ past 508.1 204.2 1 .013 107.9 908.3
≥G2∗ past ≥G2∗ no infection −328.0 176.0 1 .062 −673.1 17.0
Pairwise comparison of estimated birthweight marginal means. The mean diﬀerence is signiﬁcant at the 0.05 level. Comparisons were made for all possible
subgroup combinations but only signiﬁcant combinations are included in the table. G1 = primigravidae; ≥G2 = multigravidae.
the presence of other confounding factors such as HIV.
Interestingly, placental parasites from this region were found
to interact with several placental receptors [23]; whereas
exclusive CSA adhesion has been reported from highly
endemic areas. Of note, parity dependency of placental
infection was only signiﬁcant in the crude analysis. Although
a trend of higher infection rate in younger primigravidae was
observed, the eﬀect of gravidity could not be separated from
age. The analysis was hampered by sample size limitations,
in particular the absence of higher parities (≥G4) in the
younger age group.
Anaemia, one of the main adverse outcomes of placental
infection, was present in 22% of the study participants. The
women were, however, mainly aﬀected by moderate level of
anaemia. A median Hb level of 12.3g/dl and the low preva-
lence of severe anaemia (0.8%) may reﬂect a good general
health status but is also comparable with levels reported
previously from low- and intermediate-transmission areas in
Africa [4]. A majority of the study participants had received
iron and folic acid supplementation during pregnancy
(79.3% and 70.4%, respectively; Table 1), which may in part
explain the moderate level of anaemia observed in the study
population.
Active placental infection constituted the only signiﬁcant
risk factor for anaemia in women of all parities (OR =
2.8). In the tropics, anaemia is multifactorial and may
be caused by iron deﬁciency, parasitic infections, and
haemoglobinopathies. Available data also suggest that severe
anaemia is more common in women coinfected by malaria
and HIV, which probably is a consequence of the increased
l e v e lo fp a r a s i t a e m i ao b s e r v e di nH I V - i n f e c t e dp r e g n a n t
women [25, 26]. The potential role of infections other than
malaria was not assessed in this study. In a recent study from
Western Uganda, both hookworm infections and malaria
were reported to be considerably associated with anaemia
during pregnancy [27].
Whilststillbirthsandpretermdeliverieswereuncommon
at Mulago’s labour suite, delivery of LBW babies was
more prevalent (12.2%). No direct associations were found
between placental infection and LBW or mean birthweight
(Tables 5 and 6). Parity and placental infection were, how-
ever, found to have an interactive eﬀe c to nm e a nb i r t h w e i g h t
(P = .036). Birthweight reduction was most obvious in
primigravidae with active infection and multigravidae with
pastinfection(Tables7and8).Itishoweverdiﬃculttoassess
the signiﬁcance of the observed pattern as the role of other
confounding factors could not be assessed due to sample size
limitation.
The worst birthweight outcomes, for example, LBW,
(<2500g) have previously mainly been reported to be asso-
ciated with chronic infections [28, 29]. A recent longitudinal
study has also reported that the risk of LBW is higher with
increased frequency of malaria episodes and with infections
occurring in the second than in the third trimester or at
delivery [30]. The majority of the cases in our study was
aﬄicted by acute infection suggesting that infection was
contracted close to delivery, which may explain the lack of
association between placental infection and LBW. Moreover,Malaria Research and Treatment 9
the low transmission level in the area in combination
with better access of preventive measures in urban settings
probably decreases the number of malaria episodes and
prevents the establishment of stubborn chronic infections,
hence aﬀecting the risk of LBW.
Increased haemoglobin level was interestingly identiﬁed
as the only factor with a strong protective eﬀect against
LBW (OR = 0.83; Table 5). According to previous reports,
maternal anaemia may on its own, independent of placental
malaria infection, contribute to intrauterine growth retarda-
tion and consequently LBW, most likely via a reduction in
oxygen transport to the foetus [13].
Antenatal clinics constitute an important channel for
administration of IPT and for passing on information on
malariapreventioningeneral.Agreatmajorityofthewomen
in this study attended ANC during their pregnancy (96.8%),
which is comparable to the national levels (ANC attendance
= 94%) reported in Uganda Demographic Health Survey of
year 2000-2001. Still, relative to this, the coverage of IPT
was low (41.5%), with a majority receiving only one dose of
SP. Uganda’s national policy for IPT administration during
pregnancy is 2 doses of SP. Of note, signiﬁcantly fewer primi-
gravidaeusedIPTascomparedtomultigravidae(Table 2;G1
= 31.6%; G2-3 = 49.3%; ≥ G4 = 55.7%). The low coverage
may be explained by inadequate knowledge on how to oﬀer
IPT by the health workers and/or scarcity of the drugs.
It is pivotal to reach ﬁrst-time mothers in time, especially
since they are more prone to the most adverse outcomes of
PAM. The use of bednet was widespread (67.3%) but only
32% were strict ITN users, a number that is unacceptably
low. Using bednet signiﬁcantly protected against placental
malaria (OR = 0.56; Table 3). A trend of protective eﬀect,
although not signiﬁcant, was also observed with anaemia.
Considering their ease of use and reported beneﬁts to both
mother and the newborn baby [31], increased accessibility
and use of low-cost ITNs should be more promoted.
This study was limited by the small sample size, the
lack of HIV, and helminth infection data, which may have
weakened observed associations. The HIV seroprevalence in
pregnant women at Mulago has been around 11% during
the past recent years, a level that is higher than that of the
national estimates (6.4%) but comparable to the estimates
in other major urban hospitals in Uganda. Hence, although
we excluded AIDS patients, a proportion of HIV-positive
mothers are most probably present in the study population.
Moreover, the study may be biased by the time of patient
recruitment which was limited to weekdays between 8:00.
a.m and 5:00 p.m. Despite these limitations, our study
providesaﬁrstglimpseoftheburdenofmalariainpregnancy
at Uganda’s National Referral Hospital in an urban area of
lower transmission. It may also have bearings for the future
design of larger studies and the development of public health
policies to prevent PAM, maternal anaemia, and LBW.
Ultimately, to gain a better insight on the actual clinical
burdenofmalariainpregnancyversustransmissionleveland
to identify additional high-risk subpopulations, data from
multi-site longitudinal cohort studies are required. However,
such studies are logistically demanding, thus very infrequent
but would, for example, provide insights on disease kinetics
and enable the optimal targeting of preventive interventions,
such as IPT, during pregnancy.
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